GH Research (GHRS) News Today $8.46 +0.26 (+3.17%) (As of 12/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Fmr LLC Has $18.37 Million Position in GH Research PLC (NASDAQ:GHRS)Fmr LLC lowered its holdings in shares of GH Research PLC (NASDAQ:GHRS - Free Report) by 7.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,745,445 shares of the company's stock after sellingDecember 11, 2024 | marketbeat.comGH Research PLC (NASDAQ:GHRS) Shares Purchased by RA Capital Management L.P.RA Capital Management L.P. lifted its position in GH Research PLC (NASDAQ:GHRS - Free Report) by 1.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,686,689 shares of the company's stock after purchasingDecember 5, 2024 | marketbeat.comVerition Fund Management LLC Reduces Position in GH Research PLC (NASDAQ:GHRS)Verition Fund Management LLC cut its stake in shares of GH Research PLC (NASDAQ:GHRS - Free Report) by 7.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,057,782 shares of the company's stock after sellingDecember 2, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Shares Down 0.3% - Here's WhyGH Research (NASDAQ:GHRS) Shares Down 0.3% - Should You Sell?November 29, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Trading Up 2% - Should You Buy?GH Research (NASDAQ:GHRS) Trading 2% Higher - Time to Buy?November 28, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Trading Down 0.8% - Here's What HappenedGH Research (NASDAQ:GHRS) Stock Price Down 0.8% - Here's WhyNovember 27, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Stock Price Up 1.4% - Here's WhyGH Research (NASDAQ:GHRS) Trading Up 1.4% - What's Next?November 25, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Shares Down 5.1% - What's Next?GH Research (NASDAQ:GHRS) Shares Down 5.1% - What's Next?November 22, 2024 | marketbeat.comBrokers Offer Predictions for GH Research FY2024 EarningsGH Research PLC (NASDAQ:GHRS - Free Report) - Equities researchers at HC Wainwright cut their FY2024 EPS estimates for shares of GH Research in a research note issued to investors on Tuesday, November 19th. HC Wainwright analyst P. Trucchio now forecasts that the company will earn ($0.76) per shaNovember 22, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Trading Down 1.7% - Here's What HappenedGH Research (NASDAQ:GHRS) Stock Price Down 1.7% - Here's What HappenedNovember 21, 2024 | marketbeat.comPromising Advancements in GH Research’s Clinical Trials Boost Buy RatingNovember 21, 2024 | markets.businessinsider.comGH Research Q3 2024 Results and Clinical UpdatesNovember 21, 2024 | markets.businessinsider.comGH Research (NASDAQ:GHRS) Trading Up 2% - Time to Buy?GH Research (NASDAQ:GHRS) Stock Price Up 2% - What's Next?November 20, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Given Buy Rating at HC WainwrightHC Wainwright restated a "buy" rating and set a $40.00 price objective on shares of GH Research in a report on Wednesday.November 20, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Trading 1.2% Higher - Time to Buy?GH Research (NASDAQ:GHRS) Trading 1.2% Higher - Time to Buy?November 19, 2024 | marketbeat.comGH Research price target lowered to $28 from $31 at CanaccordNovember 19, 2024 | markets.businessinsider.comShort Interest in GH Research PLC (NASDAQ:GHRS) Increases By 7.3%GH Research PLC (NASDAQ:GHRS - Get Free Report) was the recipient of a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 1,910,000 shares, an increase of 7.3% from the October 15th total of 1,780,000 shares. Currently, 6.3% of the shares of the company are sold short. Based on an average daily trading volume, of 48,700 shares, the short-interest ratio is currently 39.2 days.November 18, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Stock Price Up 3.3% - Here's WhyGH Research (NASDAQ:GHRS) Stock Price Up 3.3% - What's Next?November 18, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Price Target Lowered to $28.00 at Canaccord Genuity GroupCanaccord Genuity Group reduced their price objective on GH Research from $31.00 to $28.00 and set a "buy" rating for the company in a research report on Monday.November 18, 2024 | marketbeat.comGH Research: Promising Developments and Financial Stability Justify Buy RatingNovember 16, 2024 | markets.businessinsider.comGH Research’s Promising Clinical Progress and Financial Strength Reaffirm Buy Rating with $39 Price TargetNovember 16, 2024 | markets.businessinsider.comGH Research (NASDAQ:GHRS) Stock Price Up 0.1% - Time to Buy?GH Research (NASDAQ:GHRS) Trading 0.1% Higher - Should You Buy?November 15, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Shares Up 0.2% - Here's What HappenedGH Research (NASDAQ:GHRS) Trading 0.2% Higher - Here's WhyNovember 14, 2024 | marketbeat.comGH Research PLC: GH Research Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNovember 14, 2024 | finanznachrichten.deGH Research Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNovember 14, 2024 | globenewswire.comGH Research (NASDAQ:GHRS) Stock Price Up 3.8% - Here's WhyGH Research (NASDAQ:GHRS) Stock Price Up 3.8% - Here's What HappenedNovember 13, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Stock Price Up 4.1% - Still a Buy?GH Research (NASDAQ:GHRS) Trading 4.1% Higher - What's Next?November 12, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Trading 3.1% Higher - Here's What HappenedGH Research (NASDAQ:GHRS) Stock Price Up 3.1% - Here's What HappenedNovember 11, 2024 | marketbeat.com3 Fast-Growing Stocks Analysts See Doubling in Price (GHRS)Clinical-stage biotech firms often have massive upside potential, but much of that possible success hinges on successful trials and product launches.November 11, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Trading Up 0.6% - What's Next?GH Research (NASDAQ:GHRS) Trading 0.6% Higher - Should You Buy?November 8, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Trading Down 0.9% - Should You Sell?GH Research (NASDAQ:GHRS) Shares Down 0.9% - Here's WhyNovember 7, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Trading Up 2.1% - What's Next?GH Research (NASDAQ:GHRS) Trading Up 2.1% - Here's WhyNovember 6, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Stock Price Up 0.6% - Time to Buy?GH Research (NASDAQ:GHRS) Stock Price Up 0.6% - Still a Buy?November 5, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Shares Up 0.7% - Still a Buy?GH Research (NASDAQ:GHRS) Trading Up 0.7% - What's Next?November 4, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Trading Up 2.2% - Here's What HappenedGH Research (NASDAQ:GHRS) Trading Up 2.2% - Here's What HappenedNovember 1, 2024 | marketbeat.comMorgan Stanley Reaffirms Their Buy Rating on Guardant Health (GH)November 1, 2024 | markets.businessinsider.comGH Research PLC (NASDAQ:GHRS) Sees Significant Growth in Short InterestGH Research PLC (NASDAQ:GHRS - Get Free Report) was the recipient of a significant growth in short interest during the month of October. As of October 15th, there was short interest totalling 1,780,000 shares, a growth of 11.3% from the September 30th total of 1,600,000 shares. Approximately 5.9% of the company's stock are short sold. Based on an average daily trading volume, of 44,300 shares, the short-interest ratio is currently 40.2 days.October 31, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Stock Price Down 1% - Time to Sell?GH Research (NASDAQ:GHRS) Stock Price Down 1% - Time to Sell?October 31, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Stock Price Up 2.8% - Still a Buy?GH Research (NASDAQ:GHRS) Stock Price Up 2.8% - Here's WhyOctober 30, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Shares Down 0.1% - What's Next?GH Research (NASDAQ:GHRS) Stock Price Down 0.1% - Time to Sell?October 29, 2024 | marketbeat.comHunger hormone suppressed by intense exercise, study suggestsOctober 29, 2024 | msn.comGH Research (NASDAQ:GHRS) Trading Up 3.3% - What's Next?GH Research (NASDAQ:GHRS) Stock Price Up 3.3% - Still a Buy?October 28, 2024 | marketbeat.comFDA is said to see “path forward” for ecstasy-based drugOctober 19, 2024 | msn.comGH Research (NASDAQ:GHRS) Stock Quotes, Forecast and News SummaryOctober 11, 2024 | benzinga.comGH Research PLC (NASDAQ:GHRS) Shares Bought by Lynx1 Capital Management LPLynx1 Capital Management LP grew its position in GH Research PLC (NASDAQ:GHRS - Free Report) by 19.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,966,726 shares of the company's stock after purchasing an additiSeptember 27, 2024 | marketbeat.comGH Research PLC (NASDAQ:GHRS) to Post FY2024 Earnings of ($0.75) Per Share, HC Wainwright ForecastsGH Research PLC (NASDAQ:GHRS - Free Report) - Equities researchers at HC Wainwright upped their FY2024 EPS estimates for GH Research in a report issued on Thursday, September 5th. HC Wainwright analyst P. Trucchio now anticipates that the company will post earnings per share of ($0.75) for the yeSeptember 9, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Given "Buy" Rating at HC WainwrightHC Wainwright restated a "buy" rating and issued a $40.00 price objective on shares of GH Research in a research report on Thursday.September 5, 2024 | marketbeat.comBuy Rating Affirmed on GH Research Amid Anticipated Phase 2 Advances and Strong Market PotentialSeptember 5, 2024 | markets.businessinsider.comIrish Biotech Firm GH Research Sees Cash Decline in Q2, Advances Psychedelic Drug TrialsSeptember 5, 2024 | msn.comMaintaining Buy Rating on GH Research Amidst CEO Transition and Promising GH001 TrialsSeptember 5, 2024 | markets.businessinsider.com Get GH Research News Delivered to You Automatically Sign up to receive the latest news and ratings for GHRS and its competitors with MarketBeat's FREE daily newsletter. Email Address How to piss off your liberal friends… and profit from it (Ad)Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies. To get the full details on the fake “energy crisis” of America, watch this now GHRS Media Mentions By Week GHRS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GHRS News Sentiment▼1.760.69▲Average Medical News Sentiment GHRS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GHRS Articles This Week▼12▲GHRS Articles Average Week Get GH Research News Delivered to You Automatically Sign up to receive the latest news and ratings for GHRS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Evotec News Arcutis Biotherapeutics News Arcus Biosciences News Nurix Therapeutics News Kiniksa Pharmaceuticals News Immunocore News Ocular Therapeutix News Mesoblast News Intellia Therapeutics News Travere Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GHRS) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GH Research PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share GH Research With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GHRS Stock Alerts